The FY2025 (Dec) proxy of Definium Therapeutics names 19 peer companies for pay. Pay versus performance data of Definium Therapeutics for that year is not on file, so it has no rank.
Pay peer group, FY2025 (Dec) proxy
| Praxis Precision Medicines | ||
| MeiraGTx Holdings | ||
| Arvinas | ||
| Solid Biosciences | ||
| Trevi Therapeutics | ||
| Fulcrum Therapeutics | ||
| Alector, Inc. | Not disclosed | Not disclosed |
| Anavex Life Sciences | Not disclosed | Not disclosed |
| Annexon, Inc. | Not disclosed | Not disclosed |
| AtaiBeckley Inc. | Not disclosed | Not disclosed |
| Compass Pathways plc | Not disclosed | Not disclosed |
| Humacyte, Inc. | Not disclosed | Not disclosed |
| Kalvista Pharmaceuticals, Inc. | Not disclosed | Not disclosed |
| Larimar Therapeutics, Inc. | Not disclosed | Not disclosed |
| LeonaBio, Inc. (f/k/a Athira Pharma) | Not disclosed | Not disclosed |
| Lineage Cell Therapeutics, Inc. | Not disclosed | Not disclosed |
| Neumora Therapeutics, Inc. | Not disclosed | Not disclosed |
| Relmada Therapeutics, Inc. | Not disclosed | Not disclosed |
| Stoke Therapeutics | Not disclosed | Not disclosed |
19 companies
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.